Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | Day Return | YTD Return |
|---|---|---|---|
| All Industries | 100% | 0.43% | 1.68% |
| Drug Manufacturers - General | 33.68% | 0.31% | 6.04% |
| Healthcare Plans | 13.39% | -0.67% | -5.10% |
| Medical Devices | 13.00% | 0.23% | 4.09% |
| Diagnostics & Research | 11.55% | 0.62% | 2.76% |
| Biotechnology | 11.13% | 1.66% | -7.73% |
| Medical Instruments & Supplies | 6.71% | 0.14% | 3.02% |
| Medical Care Facilities | 2.90% | 1.45% | 8.79% |
| Drug Manufacturers - Specialty & Generic | 2.76% | 1.72% | -6.28% |
| Medical Distribution | 2.44% | -0.87% | 10.85% |
| Health Information Services | 2.19% | 2.40% | 9.49% |
| Pharmaceutical Retailers | 0.25% | 1.76% | -30.77% |
Note: Percentage % data on heatmap indicates Day Return
All Industries
-
Largest Companies in This Sector
Name | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| 737.20 | 826.94 | 11.09% | Buy | ||||
| 489.03 | 566.61 | 7.12% | Buy | ||||
| 146.82 | 173.75 | 5.60% | Buy | ||||
| 130.12 | 138.98 | 5.21% | Buy | ||||
| 161.52 | 184.70 | 4.52% | Buy | ||||
| 576.89 | 616.78 | 3.48% | Buy | ||||
| 107.27 | 126.69 | 2.94% | Buy | ||||
| 246.82 | 270.66 | 2.89% | Buy | ||||
| 276.38 | 306.20 | 2.34% | Buy | ||||
| 25.64 | 31.10 | 2.30% | Buy |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
Name | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 140.43 | 41.319B | 0.09% | ||
| 256.54 | 21.195B | 0.10% | ||
| 128.37 | 7.632B | 0.45% | ||
| 85.52 | 7.551B | 0.35% | ||
| 55.83 | 5.76B | 0.40% |
Mutual Fund Opportunities
Name | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 207.26 | 47.432B | 0.29% | ||
| 87.39 | 47.432B | 0.29% | ||
| 128.38 | 21.195B | 0.10% | ||
| 90.22 | 15.399B | 0.80% | ||
| 90.47 | 14.712B | 0.80% |
Healthcare Research
Discover the Latest Analyst and Technical Research for This Sector
Analyst Report: Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US
RatingPrice TargetAnalyst Report: Revvity, Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
RatingPrice TargetAnalyst Report: AptarGroup, Inc.
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
RatingPrice TargetAnalyst Report: Centene Corp.
Centene is an international healthcare company. Based in St. Louis, Centene offers services to government-sponsored and commercial healthcare providers, with an emphasis on underinsured and uninsured individuals. It is the largest Medicaid managed care organization in the U.S. and a leading provider of insurance under the Affordable Care Act. Its Specialty Services segment provides a range of healthcare products and services to managed care members and other customers.
RatingPrice Target
